Neuroone Medical Technologies (NMTC) Research & Development (2017 - 2026)

Neuroone Medical Technologies' Research & Development history runs 10 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• Quarterly Research & Development fell 2.82% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (up 3.35% YoY) and the FY2025 annual result came in at $5.0 million, down 1.62% from the prior year.
• Research & Development was $1.5 million for Q1 2026 at Neuroone Medical Technologies, up from $1.4 million in the prior quarter.
• Across five years, Research & Development topped out at $4.8 million in Q3 2022 and bottomed at $37842.0 in Q1 2022.
• A 5-year average of $1.5 million and a median of $1.4 million in 2025 frame the typical range for Research & Development.
• Annual changes were most pronounced in 2022 — Research & Development tumbled 96.5% — and 2023, when it jumped 4409.05%.
• Neuroone Medical Technologies' Research & Development stood at $1.6 million in 2022, then declined by 5.13% to $1.5 million in 2023, then declined by 20.97% to $1.2 million in 2024, then gained by 18.55% to $1.4 million in 2025, then climbed by 5.64% to $1.5 million in 2026.
• Business Quant data shows NMTC's Research & Development at $1.5 million in Q1 2026, $1.4 million in Q4 2025, and $1.1 million in Q3 2025.